FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Input Sought on Controversial Menopause Expert Panel

After being criticized for attempting to bypass a formal advisory committee review of warnings associated with hormone replacement therapies, FDA anno...

Human Drugs

Guide on Aluminum Content in Parenteral Drugs

FDA issues a revised draft guidance entitled Small Volume Parenteral (SVP) Drug Products and Pharmacy Bulk Packages for Parenteral Nutrition: Aluminum...

latest-news-card-1
Biologics

FDA Probes New Death of Boy Who Got Elevidys

FDA investigates another death of a young boy who received Sarepta Therapeutics gene therapy Elevidys for Duchenne muscular dystrophy.

Human Drugs

Roche Reports Positive Data on Alzheimers Drug

Roche announces new data on its Alzheimers therapy trontinemab and its plans to begin two Phase 3 clinical trials by the end of the year.

FDA General

House Reps Urge FDA Action on Counterfeit Obesity Drugs

Bipartisan House lawmakers urge FDA to block counterfeit anti-obesity medications entering the U.S.

latest-news-card-1
Biologics

FDA Relents, Allows Gene Therapy Limited Use

FDA reverses its enforcement stance against Sarepta Therapeutics and Duchenne Muscular Dystrophy gene therapy Elevidys after determining the latest pa...

latest-news-card-1
Medical Devices

FDA Clears Stereotaxis MAGiC Sweep Catheter

FDA clears a Stereotaxis 510(k) for its MAGiC Sweep catheter, a robotically navigated high-density electrophysiology mapping catheter for diagnosing a...

latest-news-card-1
FDA General

Makary Defends CBERs Prasad After Loomer Attack

FDA commissioner Marty Makary defends CBER director Vinay Prasad from recent criticism by Trump confidant Laura Loomer.

latest-news-card-1
Human Drugs

FDA Extends Review of Bayer Menopause Drug

FDA extends by three months its review of a Bayer NDA for elinzanetant, a neurokinin 1 and neurokinin 3 receptor antagonist for treating menopause-rel...

latest-news-card-1
Human Drugs

FDA/ASCO Unite on Oncology Optimal Dosing

FDA and American Society of Clinical Oncology researchers urge drug makers to abandon outdated drug dosing strategies that are potentially putting can...